Recent advances in ocular therapeutics

International Ophthalmology Clinics

Volumn 46, Issue 4, 2006, Pages 1-6

  Whitcup, Scott M ^a  

^a ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AGENTS ACTING ON THE EYE; ATROPINE; BELLADONNA ALKALOID; CORTICOSTEROID; DACIZUMAB; FLUOCINOLONE ACETONIDE; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; PEGAPTANIB; PHYSOSTIGMINE; PILOCARPINE; RANIBIZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR;

DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RELEASE; DRUG RESEARCH; EYE DISEASE; GENE MUTATION; GLAUCOMA; HISTORY OF MEDICINE; HUMAN; INTRAOCULAR PRESSURE; LEBER CONGENITAL AMAUROSIS; LOTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; UVEITIS;

EYE DISEASES; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGY;

EID: 33750366891     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000212140.70051.33     Document Type: Review

References (18)

1. Packer M, Brandt JD. Ophthalmology's botanical heritage. Surv Ophthalmol. 1992;36:357-365.
2. Wells WC. Observations nad experiments on vision. Phil Trans Roy Soc. 1811;(Part 1):378-391.
3. Laqueur L. History of my glaucomatous illness. Am J Ophthalmol. 1929;12:984-989.
4. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37:855-868.
5. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
6. Edwards AO, Ritter R III, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
7. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
8. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232.
9. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
10. Nussenblatt RB, Fortin E, Schiffman R, et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci USA. 1999;96:7462-7466.
11. Sfikakis PP. Behcet's disease: a new target for anti-tumor necrosis factor treatment. Ann Rheum Dis. 2002;61(suppl 2):ii51-ii53.
12. El-Shabrawi Y, Hermann J. Anti-tumor necrosis factor-alpha therapy Jit infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology. 2002;109:2342-2346.
13. Lim L, Suhler EB, Smith JR. Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol. 2006;34:365-374.
14. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pagaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
15. Heier JS, Antoszyk AN, Pavan PR, et al. Ranizumab for treatment of neovascular age-related macular degeneration. A phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113:633-642.
16. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994;112:1531-1539.
17. Jaffe GJ, Martin D, Callanan D, et al. Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four week results of a multicenter randomized clinical study. Ophthalmology. 2006;113:1020-1027.
18. Osler W. Specialism in the general hospital. Johns Hopkins Hosp Bull. 1913;24:167-171.